Insider Trading & Ownership of Jeffrey Humphrey

Location
Cambridge, MA
Summary
The estimated net worth of Jeffrey Humphrey is at least $749,950 dollars as of 20 Jun 2024. Jeffrey Humphrey is the Chief Medical Officer of Lantheus Holdings, Inc. and owns shares of Lantheus Holdings, Inc. (LNTH) stock worth about $750K.
Signature
/s/ Eric M. Green, attorney-in-fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Jeffrey Humphrey and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Quick Takeaways

  • Jeffrey Humphrey has 4 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $749,950.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Lantheus Holdings, Inc. ($749,950).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Jeffrey Humphrey

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LNTH Lantheus Holdings, Inc. Chief Medical Officer $749,950 17 Jun 2024
CNST CONSTELLATION PHARMACEUTICALS INC Chief Medical Officer 15 Jul 2021
CYT Cyteir Therapeutics, Inc. Director 03 Feb 2023
DNTH Magenta Therapeutics, Inc. Chief Medical Officer 01 Aug 2022

Insider Transactions Reported by Jeffrey Humphrey:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .